Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Acadia: Q4 Earnings Snapshot
Acadia: Q4 Earnings Snapshot
Associated Press Finance
Thu, February 26, 2026 at 6:37 AM GMT+9 1 min read
In this article:
ACAD
+1.55%
SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Wednesday reported fourth-quarter earnings of $273.6 million.
On a per-share basis, the San Diego-based company said it had net income of $1.60. Earnings, adjusted for pretax gains, were 16 cents per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 12 cents per share.
The drugmaker posted revenue of $284 million in the period, falling short of Street forecasts. Eight analysts surveyed by Zacks expected $292.6 million.
For the year, the company reported profit of $391 million, or $2.30 per share. Revenue was reported as $1.07 billion.
Acadia expects full-year revenue in the range of $1.22 billion to $1.28 billion.
Acadia shares have dropped slightly more than 6% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $25.02, a climb of 32% in the last 12 months.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on ACAD at
Terms and Privacy Policy
Privacy Dashboard
More Info